Anzeige
Mehr »
Login
Dienstag, 07.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Warum der Warren Buffett des Bergbaus alles auf diese Aktie setzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
406 Leser
Artikel bewerten:
(2)

PJSC Magnit Announces the Commencing Date of the Exchange-Traded Bonds Placement

Finanznachrichten News

DJ PJSC Magnit Announces the Commencing Date of the Exchange-Traded Bonds Placement

MAGNIT PJSC (MGNT) 
PJSC Magnit Announces the Commencing Date of the Exchange-Traded Bonds Placement 
27-May-2021 / 18:31 MSK 
Dissemination of a Regulatory Announcement, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
This announcement is not for publication or distribution, directly or indirectly, in or into the United States, 
Australia, Canada, Japan or any other jurisdiction in which offers or sales would be prohibited by law. The 
distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession 
any document or other information referred to herein comes should inform themselves about and observe any such 
restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any 
such jurisdiction. 
 
This announcement does not contain or constitute an offer of, or the solicitation of an offer to purchase or subscribe 
for, the securities to any person in the United States, Australia, Canada or Japan or in any jurisdiction to whom or in 
which such offer or solicitation is unlawful. The Securities may not be offered or sold in the United States unless 
registered under the US Securities Act or offered in a transaction exempt from, or not subject to, the registration 
requirements of the US Securities Act. The offer and sale of the Securities referred to herein has not been and will 
not be registered under the US Securities Act or under the applicable securities laws of Australia, Canada or Japan. 
Subject to certain exceptions, the Securities referred to herein may not be offered or sold in Australia, Canada or 
Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada or Japan. There 
will be no public offer of the Securities in the United States, Australia, Canada or Japan or elsewhere. 
 
Members of the general public are not eligible to take part in the sale. In member states of the European Economic Area 
("EEA") (each, a "Relevant Member State"), this announcement and any offer if made subsequently is sent and addressed 
to and directed only at persons who are "qualified investors" within the meaning of the Prospectus Regulation 
(Regulation 2017/1129/EU, as amended or superseded) («Qualified Investors»). In the United Kingdom this announcement is 
sent and distributed to and directed exclusively at Qualified Investors (i) who have professional experience in matters 
relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial 
Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, or (iii) 
to whom it may otherwise lawfully be communicated, and the Securities will only be available to, and any investment 
activity to which this announcement relates will only be engaged in with, such persons and it should not be relied on 
by anyone other than such persons. 
 
THIS ANNOUNCEMENT AND MATERIALS CONTAINED IN IT ARE PROVIDED EXCLUSIVELY FOR INFORMATION AND ARE NOT AN OFFER OR A PART 
OF AN OFFER OR AN INVITATION TO ACQUIRE OR DISPOSE SECURITIES IN ANY JURISDICTION INCLUDING THE USA, AUSTRALIA, CANADA 
AND JAPAN. 
 
 
 
PJSC Magnit Announces the Commencing Date of the Exchange-Traded Bonds Placement 
 
 
Krasnodar, Russia (May 27, 2021): Magnit PJSC (MOEX and LSE: MGNT; Issuer; Company; Group), one of Russia's leading 
retailers, announces the commencing date of the exchange-traded bonds placement. 
 
Parameters of the bonds placement: 
 
        Non-convertible interest-bearing uncertified     Non-convertible interest-bearing uncertified 
        exchange-traded bonds of PJSC Magnit of the     exchange-traded bonds of PJSC Magnit of the 
        BO-002P-04 series with centralized accounting of   BO-001P-05 series with centralized accounting of 
Type of     rights, placed under the Program of the       rights, placed under the Program of the 
securities:   exchange-traded bonds of 002P series with the    exchange-traded bonds with the identification 
        identification number of 4-60525-P-002P-02E as of  number of 4-60525-P-001P-02E as of 23.10.2015 
        27.07.2016 (hereinafter - the Exchange-traded bonds (hereinafter - the Exchange-traded bonds of the 
        of the BO-002P-04 series)              BO-001P-05 series) 
        1092 (One thousand ninety second) day from the    1092 (One thousand ninety second) day from the 
Maturity date: commencing date of the Exchange-traded bonds     commencing date of the Exchange-traded bonds 
        placement                      placement 
Identification 
number of the 
Program of the 4-60525-P-002P-02E of 27.07.2016           4-60525-P-001P-02E of 23.10.2015 
Exchange-traded 
bonds: 
Placement    open subscription                  open subscription 
method: 
Pre-emptive   not provided                     not provided 
right: 
Placement 
commencing   June 2, 2021                     June 2, 2021 
date: 

Amount of securities to be placed and their nominal value:

The amount of the Exchange-traded bonds of the BO-002P-04 and BO-001P-05 series to be placed and the nominal value of the securities is specified in the Documents which contains the terms of the securities placement.

The price of the securities placement or the procedure of its determination:

The price of the exchange-traded bonds placement is specified in the Documents which contains the terms of the securities placement.

The commencing date of the securities placement:

The commencing date of placement of the Exchange-traded bonds of the BO-002P-04 and BO-001P-05 series: June 2, 2021.

The commencing date of placement of the Exchange-traded bonds of the BO-002P-04 and BO-001P-05 series may be changed by the decision of the sole executive body of the Issuer subject to the requirements for the procedure of the disclosure of information on the change of the commencing date of placement of the Exchange-traded bonds of the BO-002P-04 and BO-001P-05 series, established in accordance with the legislation of the Russian Federation, the Bonds Program and the Prospectus.

If the Issuer adopts the decision to change the commencing date of placement of the Exchange-traded bonds of the BO-002P-04 and BO-001P-05 series disclosed pursuant to the procedure specified above, the Issuer shall publish the report on change of the commencing date of the Exchange-traded bonds placement in the newswire and on the webpage on the Internet in accordance with the regulatory enactments related to financial markets not later than 1 (One) day prior to the corresponding date.

The completion date of the securities placement or the procedure of its determination:

Information on the completion date is specified in the Documents which contains the terms of the exchange-traded bonds placement.

The decision was made by the Issuer's sole executive body (Chief Executive Officer) on May 27, 2021 (Decision w/o No. of May 27, 2021).

For further information, please contact: 
 
 
       Dina Chistyak 
       Director for Investor Relations 
       dina_chistyak@magnit.ru 
       Office: +7 (861) 210 9810 x 15101 
 
       Media Inquiries          Twitter 
       press@magnit.ru          @MagnitIR 
 
 
       Note to editors 
 
       Public Joint Stock Company "Magnit" is one of Russia's leading retailers. Founded in 1994, the company is 
       headquartered in the southern Russian city of Krasnodar. As of March 31, 2021, Magnit operated 39 
       distribution centers and 21,900 stores (15,098 convenience, 471 supermarkets and 6,331 drogerie stores) 
       in 3,770 cities and towns throughout 7 federal regions of the Russian Federation. 
       In accordance with the audited IFRS 16 results for FY 2020, Magnit had revenues of RUB 1,553.8 billion 
       and an EBITDA of RUB 178.2 billion. Magnit's local shares are traded on the Moscow Exchange (MOEX: MGNT) 
       and its GDRs on the London Stock Exchange (LSE: MGNT) and it has a credit rating from Standard & Poor's 
       of BB. ----------------------------------------------------------------------------------------------------------------------- 
ISIN:      US55953Q2021 
Category Code: MSCU 
TIDM:      MGNT 
LEI Code:    2534009KKPTVL99W2Y12 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:  107936 
EQS News ID:  1201687 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------
 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1201687&application_name=news 
 

(END) Dow Jones Newswires

May 27, 2021 11:31 ET (15:31 GMT)

© 2021 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.